Structuring Present Assignment Clauses and Power of Attorney in Hardware PIIA Agreements
Present assignment clauses and irrevocable powers of attorney in hardware PIIAs secure immediate IP ownership and enable unilateral patent filings.
USPTO Rule 1.47
Meaning
Procedural mechanism at the United States Patent and Trademark Office that allows an application to proceed without the signatures of all inventors. An applicant invokes uspto rule 1.47 when an inventor refuses to sign the necessary documents or cannot be found after a diligent search. This rule ensures that a company can still protect its intellectual property even when personnel conflicts occur.
The process requires the filing of a formal petition and supporting evidence.
Filing Exception
Under uspto rule 1.47, the patent office will accept an application if the assignee can demonstrate a proprietary interest in the invention. The petition must explain why the missing inventor signature could not be obtained. This exception prevents a single disgruntled individual from blocking the entire patenting process.
It is a vital tool for companies that have high employee turnover or contentious departures.
Proof Requirement
To successfully use uspto rule 1.47, the applicant must provide a detailed declaration describing the efforts made to reach the missing inventor. This usually includes copies of certified letters and records of attempted phone calls or emails. The applicant must also show that they have a legal right to the invention through a signed employment contract.
The patent office scrutinizes these claims to ensure the rights of the inventor are not being unfairly bypassed.
Assignee Standing
Once a petition under uspto rule 1.47 is granted, the company can manage the prosecution of the patent as if it had the full cooperation of all inventors. This includes responding to office actions and paying maintenance fees. The missing inventor still retains their status as an author of the work, but they do not have the power to stop the application.
This procedure maintains the commercial value of the research investment.